Andersson Gustav, Lundgren Sebastian, Heby Margareta, Nodin Björn, Elebro Jacob, Jirström Karin
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Biomark Res. 2019 Nov 19;7:26. doi: 10.1186/s40364-019-0176-9. eCollection 2019.
Tamoxifen treatment has previously been reported to confer life-prolonging effects in patients with advanced pancreatic cancer, and most evidently so in women. None of these trials did however include biomarkers, and the relevance of female hormone signaling in pancreatic or other periampullary adenocarcinoma remains largely unexplored. The aim of this study was to examine the extent and potential clinical significance of estrogen receptor-α (ER) and progesterone receptor (PR) expression in pancreatic and other periampullary cancers.
ER and PR expression was examined using immunohistochemistry on tissue microarrays with primary tumors from a retrospective consecutive cohort of 175 patients with resected periampullary adenocarcinoma, with long-term clinical follow-up. Non-parametric and Chi square tests were applied to examine the associations of stromal ER and PR expression with patient and tumor characteristics. Kaplan-Meier analysis and log rank test were applied to illustrate survival differences in relation to ER and PR expression. Cox regression proportional hazards models were applied to examine the associations between investigative factors and risk of death and recurrence, and to test for interactions between mutation status and hormone receptor expression in relation to survival.
Expression of both ER and PR was more frequent in the tumor-associated stroma than in the epithelium. A significant prognostic interaction, independent of tumor morphology, was found between stromal PR expression and mutation status in relation to both overall and recurrence-free survival (p = 0.026 and p = 0.005), in particular in women (p = 0.002 and p = 0.005). Specifically, stromal PR expression was associated with a prolonged survival in patients with -mutated tumors, whereas the opposite was seen for wild-type tumors. The prognostic value of ER positivity was limited to the subgroup of women with tumors of pancreatic origin.
These results demonstrate that stromal PR rather than ER expression, together with mutation status, provides long-term prognostic information in patients with periampullary adenocarcinoma. Further study into the mechanistic basis for these observations may unveil important clues to the pathogenesis of these cancers and open up for the discovery of novel treatment options.
先前有报道称他莫昔芬治疗可延长晚期胰腺癌患者的生存期,在女性患者中尤为明显。然而,这些试验均未纳入生物标志物,胰腺或其他壶腹周围腺癌中女性激素信号传导的相关性仍 largely 未被探索。本研究的目的是检测雌激素受体-α(ER)和孕激素受体(PR)在胰腺和其他壶腹周围癌中的表达程度及其潜在的临床意义。
使用免疫组织化学方法在组织微阵列上检测 ER 和 PR 的表达,这些组织微阵列来自 175 例接受手术切除的壶腹周围腺癌患者的回顾性连续队列,并进行长期临床随访。应用非参数检验和卡方检验来检测基质 ER 和 PR 表达与患者及肿瘤特征之间的关联。应用 Kaplan-Meier 分析和对数秩检验来说明与 ER 和 PR 表达相关的生存差异。应用 Cox 回归比例风险模型来检测研究因素与死亡和复发风险之间的关联,并检测突变状态与激素受体表达之间关于生存的相互作用。
ER 和 PR 在肿瘤相关基质中的表达比在上皮中更常见。在基质 PR 表达与突变状态之间发现了一个独立于肿瘤形态的显著预后相互作用,与总生存期和无复发生存期相关(p = 0.026 和 p = 0.005),尤其是在女性中(p = 0.002 和 p = 0.005)。具体而言,基质 PR 表达与携带 - 突变肿瘤患者的生存期延长相关,而野生型肿瘤患者则相反。ER 阳性的预后价值仅限于胰腺起源肿瘤的女性亚组。
这些结果表明,基质 PR 而非 ER 表达,连同突变状态,为壶腹周围腺癌患者提供了长期预后信息。对这些观察结果的机制基础进行进一步研究可能会揭示这些癌症发病机制的重要线索,并为发现新的治疗选择开辟道路。